Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Key Ratios

Price & Volume
Recent Price$3.28
52 Week High$10.33
52 Week Low$3.09
Average Volume (30 days)27.54K
Share Related Items
Market Cap$16.48M
Shares Outstanding5.32M
Dividend Information
Yield %--
Annual Dividend--
Payout Ratio-833.3%
Financial Strength
Quick Ratio (MRQ)14.1
Current Ratio (MRQ)14.8
LT Debt/Capital (MRQ)0%
Total Debt/Equity (MRQ)0%
Valuation Ratios
Price/Earnings (TTM)--
Price/Sales (TTM)322.82
Price/Book (MRQ)0.62
Price/Cash Flow (TTM)(1.30)
Per Share Data
Earnings (TTM)($0.77)
Sales (TTM)--
Book Value (MRQ)$5.39
Cash Flow (TTM)($2.31)
Cash (MRQ)$4.93
Management Effectiveness
Return on Equity (TTM)-9.5%
Return on Assets (TTM)-33.2%
Return on Investment (TTM)-37.1%
Gross Margin (TTM)-3,719.0%
EBIT Margin (TTM)-23,136.2%
Profit Margin (TTM)--